Allworth Financial LP Novartis Ag Transaction History

Allworth Financial LP

$17.3 Billion
Q4 2024

A detailed history of Allworth Financial LP transactions in Novartis Ag stock. As of the latest transaction made, Allworth Financial LP holds 95,768 shares of NVS stock, worth $10.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

95,768

Previous 3,902 2354.33%

Holding current value

$10.3 Million

Previous $448,000 1980.13%

% of portfolio

0.05%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$96.78 - $117.18 $8.89 Million - $10.8 Million	91,866 Added 2354.33%	95,768 $9.32 Million
Q3 2024 Oct 23, 2024	BUY	$106.13 - $120.89 $9,127 - $10,396	86 Added 2.25%	3,902 $448,000
Q2 2024 Jul 23, 2024	BUY	$92.57 - $107.37 $7,961 - $9,233	86 Added 2.31%	3,816 $406,000
Q1 2024 Apr 25, 2024	SELL	$95.27 - $108.47 $4,763 - $5,423	-50 Reduced 1.32%	3,730 $360,000
Q4 2023 Jan 24, 2024	BUY	$92.27 - $101.54 $67,633 - $74,428	733 Added 24.06%	3,780 $381,000
Q3 2023 Oct 31, 2023	SELL	$94.73 - $105.13 $16,861 - $18,713	-178 Reduced 5.52%	3,047 $310,000
Q2 2023 Jul 18, 2023	SELL	$92.52 - $104.91 $1,572 - $1,783	-17 Reduced 0.52%	3,225 $325,000
Q1 2023 Apr 18, 2023	BUY	$80.03 - $92.81 $9,123 - $10,580	114 Added 3.64%	3,242 $298,000
Q4 2022 Jan 13, 2023	SELL	$75.55 - $92.52 $7,026 - $8,604	-93 Reduced 2.89%	3,128 $0
Q3 2022 Oct 18, 2022	BUY	$74.61 - $87.26 $76,400 - $89,354	1,024 Added 46.61%	3,221 $245,000
Q2 2022 Jul 13, 2022	BUY	$80.52 - $93.75 $15,459 - $18,000	192 Added 9.58%	2,197 $186,000
Q1 2022 Apr 22, 2022	SELL	$80.11 - $90.62 $3,204 - $3,624	-40 Reduced 1.96%	2,005 $176,000
Q4 2021 Jan 21, 2022	BUY	$79.7 - $88.13 $48,537 - $53,671	609 Added 42.41%	2,045 $179,000
Q3 2021 Nov 02, 2021	BUY	$81.78 - $95.14 $84,478 - $98,279	1,033 Added 256.33%	1,436 $117,000
Q2 2021 Aug 02, 2021	BUY	$85.24 - $94.15 $14,831 - $16,382	174 Added 75.98%	403 $37,000
Q1 2021 Apr 29, 2021	SELL	$83.5 - $98.47 $4,759 - $5,612	-57 Reduced 19.93%	229 $20,000
Q4 2020 Jan 26, 2021	SELL	$78.07 - $94.43 $19,517 - $23,607	-250 Reduced 46.64%	286 $27,000
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $6,406 - $7,098	-78 Reduced 12.7%	536 $47,000
Q2 2020 Jul 24, 2020	BUY	$80.93 - $91.1 $4,046 - $4,555	50 Added 8.87%	614 $54,000
Q1 2020 Apr 17, 2020	BUY	$70.67 - $99.01 $3,604 - $5,049	51 Added 9.94%	564 $46,000
Q4 2019 Jan 16, 2020	SELL	$84.35 - $95.37 $28,341 - $32,044	-336 Reduced 39.58%	513 $49,000
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $7,690 - $9,465	-102 Reduced 10.73%	849 $78,000
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $46,171 - $52,809	613 Added 181.36%	951 $91,000
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $7,366 - $8,202	100 Added 42.02%	338 $29,000
Q2 2018 Aug 08, 2018	BUY	$64.91 - $73.36 $259 - $293	4 Added 1.71%	238 $18,000
Q4 2017 Feb 22, 2018	SELL	$72.33 - $77.64 $9,547 - $10,248	-132 Reduced 36.07%	234 $20,000
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $6,746 - $7,031	91 Added 33.09%	366 $31,000
Q2 2017 Aug 07, 2017	BUY	N/A	275	275 $23,000

Others Institutions Holding NVS

# of Institutions

1,474

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Novartis Ag Transaction History